Answers are grounded in this paper and cite their sources.
We read with interest the recent report of concurrent development of myeloma in monozygotic twins (Olujohungbe et al, 2006). The report bears similarities with a case reported from our centre (Snowden & Greaves, 1995), in which there was onset of symptomatic IgA lambda myeloma in two identical twins within 10 months of each other. Interestingly, as in Olujohungbe's case, the occupational history in both of the twins included lifelong work in the building trade. However in their case the IgG monoclones (IgG kappa and IgG lambda) differed between the twins. The concurrence of myeloma in monozygotic twins has been described in two other reports (Judson et al, 1985; Comotti et al, 1987) with an additional report of Waldenstrom macroglobulinaemia (Fine et al, 1986). The reports vary in whether the paraproteins are identical. The significance of such cases is uncertain. Although monozygotic twins share the majority of their genome, genetic variability may occur in twins for a number of reasons, including somatic mutation of immunoglobulin genes X chromosome inactivation (in females) and with epigenetic events resulting in complex phenotypic differences. Further studies in monozygotic twins concordant and discordant for myeloma may provide useful pathogenetic information. Firstly, as the evolution of myeloma has been estimated to originate from single cell transformation 2–3 decades before presentation (Hobbs, 1969), detailed occupational and social histories from both twins may provide information relating to environmental agents. Secondly, modern laboratory techniques may provide information about commonality of clonality, gene expression and methylation status between monozygotic twins. In the cases described to date, including that of Olujohungbe et al (2006), such studies have not been available. Investigation of future rare cases with molecular techniques may provide valuable insights into the role of genetics and environment in the pathogenesis of plasma cell dyscrasias. As the frequency of cases of myeloma in twins appears to be extremely low, identification of monozygotic twins with monoclonal gammopathy, which occurs in over 3–5% of individuals over 50 years, may be an alternative means of providing similar information.
No takes yet. Share an insight, caveat, or question.
Cutting et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: